NCT07483268Active, not recruitingNot Applicable
A Prospective Study of Stapokibart Injection in Patients With CRSwNP
Chengdu Kangnuoxing Biopharma,Inc.1 site in 1 country600 target enrollmentStarted: May 29, 2026Last updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 600
- Locations
- 1
Study Overview
Brief Summary
This study is a open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with CRSwNP.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Participants aged 18 years or older at the time of informed consent and provide voluntary informed consent to participate in the study before inclusion in the study.
- •Physician decision to treat the participant with Stapokibart Injection for CRSwNP (according to the China-specific prescribing information) made prior to and independently of the participant's participation in the study.
Exclusion Criteria
- •Known history of allergic reaction to Stapokibart Injection.
- •Participants currently or plan participating in any interventional clinical trial.
- •Participants with hematologic malignancies.
- •Women with pregnant.
- •Any condition that, in the opinion of the Investigator, may interfere with the participant's ability to participate in the study.
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)NCT07459556Chengdu Kangnuoxing Biopharma,Inc.400
Recruiting
Not Applicable
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)Atopic Dermatitis (AD)NCT07544862Chengdu Kangnuoxing Biopharma,Inc.1,000
Recruiting
Phase 2
A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET AbnormalitiesNCT07308106Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.70
Not yet recruiting
Not Applicable
Using Injectable Platelet-Rich Fibrin (i-PRF) to Treat Under-Eye Aging: A Clinical StudyCTRI/2026/04/107424Datta Meghe Medical College25
Recruiting
Not Applicable
A comparative study to evaluate the insertion of postpartum intrauterine contraceptive device with the new inserter versus Kelly forceps .CTRI/2024/08/072917Dr Palak60